APP
NTUS

Avantax Planning Partners’s Natus Medical Inc NTUS Stock Holding History

Avantax Planning Partners’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-575
Closed -$20K – 1309
2018
Q3 		$20K Buy
+575
New +$20.3K ﹤0.01% 707
2018
Q2 		– Sell
-563
Closed -$19K – 1633
2018
Q1 		$19K Buy
+563
New +$17.8K ﹤0.01% 801

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Avantax Planning Partners's NTUS Position: Q4 2018 in Review

Avantax Planning Partners sold out of Natus Medical Inc (NTUS) in Q4 2018, closing a stake of 575 shares — an estimated $20K sold.

Avantax Planning Partners first reported a position in NTUS in Q1 2018 and held it in 2 quarters. The position peaked at $20K in Q3 2018. 174 funds tracked by Wall St. Rank hold NTUS as of Q4 2018.

  • Avantax Planning Partners reported no remaining Natus Medical Inc position as of Q4 2018 after selling out during the quarter.
  • Avantax Planning Partners sold 575 Natus Medical Inc shares in Q4 2018, an estimated $20K.
  • Avantax Planning Partners first reported a position in Natus Medical Inc in Q1 2018 and held it in 2 quarters.
  • Avantax Planning Partners's Natus Medical Inc position peaked at $20K in Q3 2018.
  • 174 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2018.

Based on Avantax Planning Partners's 13F filing for Q4 2018, filed 14 Feb 2019.